Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

por Hong, Junshik, Lee, Yoo Jin, Bae, Sung Hwa, Yi, Jun Ho, Park, Sungwoo, Chang, Myung Hee, Park, Young Hoon, Hyun, Shin Young, Chung, Joo-Seop, Jang, Ji Eun, Jung, Joo Young, Jeon, So-Yeon, Song, Seo-Young, Kim, Hawk, Kim, Dae Sik, Kim, Sung-Hyun, Kim, Min Kyoung, Han, Sang Hoon, Park, Seonyang, Kim, Yoo-Jin, Lee, Je-Hwan, AML, on behalf of the, Hematology, MDS Working Party of the Korean Society of
Publicado 2021